Metabolische Effekte von Beta-Rezeptorenblockern: was muss man beachten?
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Buch |
Sprache: | Undetermined |
Veröffentlicht: |
Mainz
Kirchheim
1993
|
Ausgabe: | 1. Aufl. |
Schlagworte: | |
Beschreibung: | Literaturverz. S. 13 - 16 |
Beschreibung: | 16 S. |
ISBN: | 3874090728 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV026126364 | ||
003 | DE-604 | ||
005 | 20110228 | ||
007 | t | ||
008 | 110326s1993 |||| 00||| und d | ||
015 | |a 94,A20,0646 |2 dnb | ||
020 | |a 3874090728 |9 3-87409-072-8 | ||
035 | |a (OCoLC)75433704 | ||
035 | |a (DE-599)BVBBV026126364 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | |a und | ||
049 | |a DE-188 | ||
100 | 1 | |a Sawicki, Peter |e Verfasser |4 aut | |
245 | 1 | 0 | |a Metabolische Effekte von Beta-Rezeptorenblockern |b was muss man beachten? |c Peter T. Sawicki und Michael Berger |
250 | |a 1. Aufl. | ||
264 | 1 | |a Mainz |b Kirchheim |c 1993 | |
300 | |a 16 S. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
500 | |a Literaturverz. S. 13 - 16 | ||
650 | 0 | 7 | |a Hypertonie |0 (DE-588)4026372-1 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Beta-Blocker |0 (DE-588)4006088-3 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Hypertonie |0 (DE-588)4026372-1 |D s |
689 | 0 | 1 | |a Beta-Blocker |0 (DE-588)4006088-3 |D s |
689 | 0 | 2 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |D s |
689 | 0 | |5 DE-188 | |
700 | 1 | |a Berger, Michael |e Sonstige |4 oth | |
999 | |a oai:aleph.bib-bvb.de:BVB01-021716685 |
Datensatz im Suchindex
_version_ | 1804144569144573952 |
---|---|
any_adam_object | |
author | Sawicki, Peter |
author_facet | Sawicki, Peter |
author_role | aut |
author_sort | Sawicki, Peter |
author_variant | p s ps |
building | Verbundindex |
bvnumber | BV026126364 |
ctrlnum | (OCoLC)75433704 (DE-599)BVBBV026126364 |
edition | 1. Aufl. |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01266nam a2200385 c 4500</leader><controlfield tag="001">BV026126364</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20110228 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">110326s1993 |||| 00||| und d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">94,A20,0646</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3874090728</subfield><subfield code="9">3-87409-072-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)75433704</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV026126364</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">und</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-188</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sawicki, Peter</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Metabolische Effekte von Beta-Rezeptorenblockern</subfield><subfield code="b">was muss man beachten?</subfield><subfield code="c">Peter T. Sawicki und Michael Berger</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. Aufl.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Mainz</subfield><subfield code="b">Kirchheim</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">16 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturverz. S. 13 - 16</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hypertonie</subfield><subfield code="0">(DE-588)4026372-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Beta-Blocker</subfield><subfield code="0">(DE-588)4006088-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Hypertonie</subfield><subfield code="0">(DE-588)4026372-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Beta-Blocker</subfield><subfield code="0">(DE-588)4006088-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-188</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berger, Michael</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-021716685</subfield></datafield></record></collection> |
id | DE-604.BV026126364 |
illustrated | Not Illustrated |
indexdate | 2024-07-09T23:05:38Z |
institution | BVB |
isbn | 3874090728 |
language | Undetermined |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-021716685 |
oclc_num | 75433704 |
open_access_boolean | |
owner | DE-188 |
owner_facet | DE-188 |
physical | 16 S. |
publishDate | 1993 |
publishDateSearch | 1993 |
publishDateSort | 1993 |
publisher | Kirchheim |
record_format | marc |
spelling | Sawicki, Peter Verfasser aut Metabolische Effekte von Beta-Rezeptorenblockern was muss man beachten? Peter T. Sawicki und Michael Berger 1. Aufl. Mainz Kirchheim 1993 16 S. txt rdacontent n rdamedia nc rdacarrier Literaturverz. S. 13 - 16 Hypertonie (DE-588)4026372-1 gnd rswk-swf Beta-Blocker (DE-588)4006088-3 gnd rswk-swf Arzneimittelnebenwirkung (DE-588)4003134-2 gnd rswk-swf Hypertonie (DE-588)4026372-1 s Beta-Blocker (DE-588)4006088-3 s Arzneimittelnebenwirkung (DE-588)4003134-2 s DE-188 Berger, Michael Sonstige oth |
spellingShingle | Sawicki, Peter Metabolische Effekte von Beta-Rezeptorenblockern was muss man beachten? Hypertonie (DE-588)4026372-1 gnd Beta-Blocker (DE-588)4006088-3 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd |
subject_GND | (DE-588)4026372-1 (DE-588)4006088-3 (DE-588)4003134-2 |
title | Metabolische Effekte von Beta-Rezeptorenblockern was muss man beachten? |
title_auth | Metabolische Effekte von Beta-Rezeptorenblockern was muss man beachten? |
title_exact_search | Metabolische Effekte von Beta-Rezeptorenblockern was muss man beachten? |
title_full | Metabolische Effekte von Beta-Rezeptorenblockern was muss man beachten? Peter T. Sawicki und Michael Berger |
title_fullStr | Metabolische Effekte von Beta-Rezeptorenblockern was muss man beachten? Peter T. Sawicki und Michael Berger |
title_full_unstemmed | Metabolische Effekte von Beta-Rezeptorenblockern was muss man beachten? Peter T. Sawicki und Michael Berger |
title_short | Metabolische Effekte von Beta-Rezeptorenblockern |
title_sort | metabolische effekte von beta rezeptorenblockern was muss man beachten |
title_sub | was muss man beachten? |
topic | Hypertonie (DE-588)4026372-1 gnd Beta-Blocker (DE-588)4006088-3 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd |
topic_facet | Hypertonie Beta-Blocker Arzneimittelnebenwirkung |
work_keys_str_mv | AT sawickipeter metabolischeeffektevonbetarezeptorenblockernwasmussmanbeachten AT bergermichael metabolischeeffektevonbetarezeptorenblockernwasmussmanbeachten |